Calpains: Markers of tumor aggressiveness?

Experimental Cell Research

Volumn 316, Issue 9, 2010, Pages 1587-1599

  Roumes, Hélène ^a   Leloup, Ludovic ^b   Dargelos, Elise ^a   Brustis, Jean Jacques ^a   Daury, Laetitia ^a   Cottin, Patrick ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Calpains; Cytoskeleton; Invasion; Migration; Rhabdomyosarcoma cells

Indexed keywords

ALPHA ACTIN; BETA ACTIN; CALPAIN;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; MYOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RHABDOMYOSARCOMA; SARCOMA CELL; UPREGULATION;

EID: 77952892154     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.017     Document Type: Article

References (37)

1. Dias P., Parham D.M., Shapiro D.N., Webber B.L., Houghton P.J. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am. J. Pathol. 1990, 137:1283-1291.
2. Parham D.M., Webber B., Holt H., Williams W.K., Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an intergroup rhabdomyosarcoma study project. Cancer 1991, 67:3072-3080.
3. Fredericks W.J., Galili N., Mukhopadhyay S., et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 1995, 15:1522-1535.
4. Scrable H.J., Witte D.P., Lampkin B.C., et al. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 1987, 329:645-647.
5. Dagher R., Helman L. Rhabdomyosarcoma: an overview. Oncologist 1999, 4:34-44.
6. Mamoune A., Luo J.H., Lauffenburger D.A., Wells A. Calpain-2 as a target for limiting prostate cancer invasion. Cancer Res. 2003, 63:4632-4640.
7. Xu L., Deng X. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion. J. Biol. Chem. 2004, 279:53683-53690.
8. Xu L., Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J. Biol. Chem. 2006, 281:35567-35575.
9. Schád E., Farcas A., Jékely G., Tompa P., Friedrich P. A novel human small subunit of calpains. Biochem. J. 2002, 362:383-388.
10. Wendt A., Thompson V.F., Goll D.E. Interaction of calpastatin with calpain: a review. Biol. Chem. 2004, 385:465-472.
11. Raynaud P., Jayat-Vignoles C., Laforêt M.P., Levéziel H., Amarger V. Four promoters direct expression of the calpastatin gene. Arch. Biochem. Biophys. 2005, 437:69-77.
12. 2+-dependent proteinase. J. Biol. Chem. 1987, 26:5839-5851.
13. Zhu C.H., Mouly V., Cooper R.N., et al. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell. 2007, 6:515-523.
14. Mazères G., Leloup L., Daury L., Cottin P., Brustis J.J. Myoblast attachment and spreading are regulated by different patterns by ubiquitous calpains. Cell. Motil. Cytoskeleton 2006, 63:193-207.
15. Carragher N.O., Fonseca B.D., Frame M.C. Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 2004, 6:53-73.
16. Leloup L., Mazères G., Daury L., Cottin P., Brustis J.J. Involvement of calpains in growth factor-mediated migration. Int. J. Biochem. Cell. Biol. 2006, 38:2049-2063.
17. Brustis J.J., Elamrani N., Balcerzak D., et al. Rat myoblast fusion requires exteriorized m-calpain activity. Eur. J. Cell. Biol. 1994, 64:320-327.
18. Leloup L., Daury L., Mazères G., Cottin P., Brustis J.J. Involvement of the ERK/MAP kinase signaling pathway in milli-calpain activation and myogenic cell migration. Int. J. Biochem. Cell. Biol. 2007, 39:1177-1189.
19. Lambrechts A., Van Troys M., Ampe C. The actin cytoskeleton in normal and pathological cell motility. Int. J. Biochem. Cell. Biol. 2004, 36:1890-1909.
20. Braun C., Engel M., Seifert M., et al. Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int. J. Cancer 1999, 84:6-9.
21. Reichrath J., Welter C., Mitschele T., Classen U., Meineke V., Tilgen W., Seifert M. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. J. Pathol. 2003, 199:509-516.
22. Lakshmikuttyamma A., Selvakumar P., Kanthan R., Kanthan S.C., Sharma R.K. Overexpression of m-calpain in human colorectal adenocarcinomas. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1604-1609.
23. Samanta K., Kar P., Ghosh B., Chakraborti T., Chakraborti S. Localization of m-calpain and calpastatin and studies of their association in pulmonary smooth muscle endoplasmic reticulum. Biochim. Biophys. Acta 2007, 1770:1297-2307.
24. Howard E.W., Leung S.C., Yuen H.F., et al. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer. Clin. Exp. Metastasis 2008, 25:497-508.
25. Kassis J., Radinsky R., Wells A. Motility is rate-limiting for invasion of bladder carcinoma cell lines. Int. J. Biochem. Cell. Biol. 2002, 34:762-775.
26. Taylor R.G., Geesink G.H., Thompson V.F., Koohmaraie M., Goll D.E. Is Z-disk degradation responsible for postmortem tenderization?. J. Anim. Sci. 1995, 73:1351-1367.
27. Dourdin N., Bhatt A.K., Dutt P., et al. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J. Biol. Chem. 2001, 276:48382-48388.
28. Calle Y., Carragher N.O., Thrasher A.J., Jones G.E. Inhibition of calpain stabilises podosomes and impairs dendritic cell motility. J. Cell. Sci. 2006, 119:2375-2385.
29. Glading A., Lauffenburger D.A., Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell. Biol. 2002, 12:46-54.
30. Carragher N.O., Fincham V.J., Riley D., Frame M.C. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J. Biol. Chem. 2001, 276:4270-4275.
31. Perrin B.J., Amann K.J., Huttenlocher A. Proteolysis of cortactin by calpain regulates membrane protrusion during cell migration. Mol. Biol. Cell. 2006, 17:239-250.
32. Huttenlocher A., Palecek S.P., Lu Q., et al. Regulation of cell migration by the calcium-dependent protease calpain. J. Biol. Chem. 1997, 272:32719-32722.
33. Potter D.A., Tirnauer J.S., Janssen R., et al. Calpain regulates actin remodelling during cell spreading. J. Cell. Biol. 1998, 141:647-662.
34. Dedieu S., Poussard S., Mazères G., Grise F., Dargelos E., Cottin P., Brustis J. Myoblasts migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp. Cell. Res. 2004, 292:187-200.
35. Emori Y., Saigo K. Calpain localization changes in coordination with actin-related cytoskeletal changes during early embryonic development of Drosophila. J. Biol. Chem. 1994, 269:25137-25142.
36. Katoh K., Kano Y., Ookawara S. Rho-kinase dependent organization of stress fibers and focal adhesions in cultured fibroblasts. Genes to Cells 2007, 12:623-638.
37. Fan D.G., Dai J.Y., Tang J., Wu M.M., Sun S.G., Jiang J.L., Fan Q.Y. Silencing of calpain expression reduces the metastatic potential of human osteosarcoma cells. Cell. Biol. Int. 2009, 33:1263-1267.